| 李旭清,张俊伟,吕晶丽.我国复发难治性淋巴瘤治疗策略分析[J].中国肿瘤,2016,25(10):830-834. |
| 我国复发难治性淋巴瘤治疗策略分析 |
| Strategy for the Treatment of Relapsed or Refractory Lymphoma in China |
| 投稿时间：2015-04-20 |
| DOI：10.11735/j.issn.1004-0242.2016.10.A017 |
|
 |
| 中文关键词: 复发难治性淋巴瘤 循证医学 指南 |
| 英文关键词:relapsed and refractory lymphoma evidence-based medicine guide |
| 基金项目:山西省软科学研究项目（2011041073-01） |
|
| 摘要点击次数: 2067 |
| 全文下载次数: 783 |
| 中文摘要: |
| 摘 要：对比分析国内外淋巴瘤权威指南中关于不同类型复发难治性淋巴瘤的诊治信息，并收集国内外复发难治性淋巴瘤诊治的循证医学证据。与国外指南相比，我国的复发难治性淋巴瘤治疗方案包括病种较少；内容相对简单，操作力不强；未注明循证医学研究证据，可参考性有待提高。我国复发难治性淋巴瘤的定义、诊断标准有待规范，临床实践指南内容有待扩充，应开展复发难治性淋巴瘤的高质量临床研究，充分收集循证医学研究证据，提高临床实践指南的可操作性，规范复发难治淋巴瘤诊治。 |
| 英文摘要: |
| Abstract：By the method of evidence-based medicine，the diagnosis information in abroad authoritative guide of different types relapsed and refractory lymphoma at home and abroad were analyzed，and the evidence of evidence-based medicine were collected. Compared with foreign guidelines，our treatment program of relapsed and refractory lymphoma included less diseases，the content was relatively simple，and the operating force was not strong. At the same time，our treatment strategy did not indicate the research evidence of evidence-based medical，its reference function needed to be improved. The definition and diagnostic criteria of relapsed and refractory lymphoma in China should be standardized，and the content of clinical practice guidelines needs to be expanded. High quality clinical research of relapsed and refractory lymphoma should be carried out，the full collection of evidence-based medical research evidence could improve operability of clinical practice guidelines，and standardize diagnosis and treatment of relapsed or refractory lymphoma in China. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |